CLEAN ENERGY FUELS CORP (CLNE)

US1844991018 - Common Stock

2.38  +0.05 (+2.15%)

After market: 2.4071 +0.03 (+1.14%)

Fundamental Rating

2

Overall CLNE gets a fundamental rating of 2 out of 10. We evaluated CLNE against 214 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of CLNE is average, but there are quite some concerns on its profitability. While showing a medium growth rate, CLNE is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

CLNE had negative earnings in the past year.
In the past year CLNE had a positive cash flow from operations.
CLNE had negative earnings in 4 of the past 5 years.
In the past 5 years CLNE always reported a positive cash flow from operatings.

1.2 Ratios

CLNE's Return On Assets of -7.90% is on the low side compared to the rest of the industry. CLNE is outperformed by 89.72% of its industry peers.
CLNE has a worse Return On Equity (-13.69%) than 86.45% of its industry peers.
Industry RankSector Rank
ROA -7.9%
ROE -13.69%
ROIC N/A
ROA(3y)-7.68%
ROA(5y)-4.36%
ROE(3y)-11.43%
ROE(5y)-6.48%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CLNE's Gross Margin of 19.17% is on the low side compared to the rest of the industry. CLNE is outperformed by 69.63% of its industry peers.
CLNE's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CLNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.26%
GM growth 5Y-13.03%

4

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLNE has been increased compared to 1 year ago.
CLNE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLNE has a worse debt to assets ratio.

2.2 Solvency

CLNE has an Altman-Z score of -0.01. This is a bad value and indicates that CLNE is not financially healthy and even has some risk of bankruptcy.
CLNE has a worse Altman-Z score (-0.01) than 72.43% of its industry peers.
A Debt/Equity ratio of 0.36 indicates that CLNE is not too dependend on debt financing.
CLNE's Debt to Equity ratio of 0.36 is in line compared to the rest of the industry. CLNE outperforms 57.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z -0.01
ROIC/WACCN/A
WACC8.39%

2.3 Liquidity

A Current Ratio of 2.87 indicates that CLNE has no problem at all paying its short term obligations.
The Current ratio of CLNE (2.87) is better than 81.31% of its industry peers.
CLNE has a Quick Ratio of 2.59. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.59, CLNE belongs to the top of the industry, outperforming 80.84% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.87
Quick Ratio 2.59

4

3. Growth

3.1 Past

CLNE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -400.00%.
Looking at the last year, CLNE shows a small growth in Revenue. The Revenue has grown by 1.18% in the last year.
Measured over the past years, CLNE shows a small growth in Revenue. The Revenue has been growing by 4.18% on average per year.
EPS 1Y (TTM)-400%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q0%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y13.38%
Revenue growth 5Y4.18%
Revenue growth Q2Q-6.1%

3.2 Future

Based on estimates for the next years, CLNE will show a very strong growth in Earnings Per Share. The EPS will grow by 59.52% on average per year.
The Revenue is expected to grow by 15.11% on average over the next years. This is quite good.
EPS Next Y-94.29%
EPS Next 2Y70.18%
EPS Next 3Y45.89%
EPS Next 5Y59.52%
Revenue Next Year4.44%
Revenue Next 2Y8.04%
Revenue Next 3Y11.53%
Revenue Next 5Y15.11%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLNE. In the last year negative earnings were reported.
Also next year CLNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as CLNE's earnings are expected to grow with 45.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y70.18%
EPS Next 3Y45.89%

0

5. Dividend

5.1 Amount

No dividends for CLNE!.
Industry RankSector Rank
Dividend Yield N/A

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (5/3/2024, 7:00:00 PM)

After market: 2.4071 +0.03 (+1.14%)

2.38

+0.05 (+2.15%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap531.36M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.9%
ROE -13.69%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19.17%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.87
Quick Ratio 2.59
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-400%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-94.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.18%
Revenue growth 3Y13.38%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y